Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
filingDate |
2005-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ead4634ddb0b184baf5930cc38f6de9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8efd9c24481315fbce6f111b0b3e0ab9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7088a1cc69de50826ef020758bc05db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8244cc28db5dc583df887ef167a34f11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93a1346fcc200aff7054e7801da7810a |
publicationDate |
2005-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2564025-A1 |
titleOfInvention |
A method for the treatment or prevention of cardiac hypertrophy |
abstract |
The present invention relates to a method for the treatment or prevention of cardiac hypertrophy or diastolic heart failure resulting from cardiac hypertrophy by administering levosimendan or its metabolite (II) or any of their pharmaceutically acceptable salts, to a mammal in need of such treatment. |
priorityDate |
2004-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |